Skip to content

Monitoring vital data by smartwatches in patients with head and neck cancer – a feasibility study

Monitoring vital data by smartwatches in patients with head and neck cancer – a feasibility study - MOVE-1

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00032658
Enrollment
35
Registered
2023-09-11
Start date
2024-05-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Interventions

Group 1: Patients with head and neck cancer wear a smartwatch for 7 days (24 h) and complete before and after questionnaires.

Sponsors

Universitätsmedizin Rostock
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Sufficient knowledge of German - Patients with tumor disease in the oral, maxillofacial and cervical region under antineoplastic or palliative therapy (radiotherapy, surgery, chemotherapy or immunotherapy) or in follow-up care - Patient must be able to perform the tasks required in the study.

Exclusion criteria

Exclusion criteria: - Non-consenting patients - Failure to meet an inclusion criterion

Design outcomes

Primary

MeasureTime frame
Adherence to wear a smartwatch for one week (24/7) and extent of recording of target parameters. - evaluation of the data on the smartphone - following the specified wearing time

Secondary

MeasureTime frame
a) Frequency of use of the display function of the smartwatch to query the physical activity Physical activity (e.g., step count). -via log, recording every day of the week b) Amount and intensity of physical activity and time spent inactive. - evaluation of the data on the smartphone - following the specified wearing time c) subjective physical activity - Saltin-Grimby Physical Activity Level Scale -once before the start of the three-wearing period d) Quality of life incl. symptom burden - Quality of life questionnaires of the EORTC: QLQ-C30 and QLQ - H&N43 - once after the wearing period

Countries

Germany

Contacts

Public ContactSabine Felser

Universitätsmedizin Rostock

sabine.felser@med.uni-rostock.de+49 381 494-7395

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026